January 2012 BrainStorm Announces Clinical Data for Safety and Supporting Efficacy of NurOwn(TM) Based on Initial Phase I/II Results GATC Biotech and LifeCodexx Complete Recruitment of Blood Samples for Clinical Study of Trisomy 21 Diagnostic Test
January 2012
BrainStorm Announces Clinical Data for Safety and Supporting Efficacy of NurOwn(TM) Based on Initial Phase I/II Results
GATC Biotech and LifeCodexx Complete Recruitment of Blood Samples for Clinical Study of Trisomy 21 Diagnostic Test
About Life Sciences Industry News Subscribe Advertise Contribute
